Literature DB >> 6136880

Neuropathology of spasmodic dysphonia.

S D Schaefer.   

Abstract

Spasmodic dysphonia is a devastating voice disorder of unknown etiology, with a variable clinical presentation and response to treatment. Three independent evaluations of brain stem function were performed on spasmodic dysphonic patients, and age and sex-matched controls. Statistically significant (p less than 0.01 approximately 0.05) differences were noted between these groups, and the findings were consistent with impairment of somatic and visceral brain stem pathways. A significant correlation (p less than 0.05) was found between the severity of tested central nervous system impairment and vocal tremor, number of associated neurologic signs and duration of illness. Possible etiologies (viral or traumatic), age, and sex, did not correlate with the severity of brain stem impairment. Clinical signs and the brain stem findings appeared to stabilize 3 to 5 years after onset of dysphonia. The investigation of other spasmodic cranial nerve disorders afforded insight into the etiology and therapy for spasmodic dysphonia. Drawing upon previous observations and the results of the brain stem tests, two models are proposed for neuronal processing in spasmodic dysphonia, and future strategies are discussed. The evidence cited in this research project are consistent with spasmodic dysphonia being one of several spasmodic brain stem disorders with variable presentation which are known by the cranial nerve nuclei or pathways of major clinical involvement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136880     DOI: 10.1288/00005537-198309000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

Review 1.  Laryngospasm in neurological diseases.

Authors:  Hans-Jürgen Gdynia; Jan Kassubek; Anne-Dorte Sperfeld
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Paroxysmal Laryngospasm: A Rare Condition That Respiratory Physicians Must Distinguish from Other Diseases with a Chief Complaint of Dyspnea.

Authors:  Yu Bai; Xi-Rui Jing; Yun Xia; Xiao-Nan Tao
Journal:  Can Respir J       Date:  2020-07-04       Impact factor: 2.409

5.  Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia.

Authors:  Selmin Karatayli Ozgursoy; Emily R Vargas; Michael G Heckman; Amy L Rutt
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06       Impact factor: 2.124

6.  Adduction laryngeal dystonia: proposal and evaluation of nasofibroscopy.

Authors:  Noemi Grigoletto De Biase; Paula Lorenzon; Mariana Dantas Aumond Lebl; Marina Padovani; Ingrid Gielow; Glaucya Madazio; Miriam Moraes
Journal:  Braz J Otorhinolaryngol       Date:  2006 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.